Deeper Dive: Understanding Checkpoint Therapeutics Inc (CKPT) Through its Various Ratios

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Checkpoint Therapeutics Inc (NASDAQ: CKPT) closed at $3.64 in the last session, up 2.82% from day before closing price of $3.54. In other words, the price has increased by $2.82 from its previous closing price. On the day, 0.5 million shares were traded. CKPT stock price reached its highest trading level at $3.65 during the session, while it also had its lowest trading level at $3.41.

Ratios:

We take a closer look at CKPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.

On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.

On January 20, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $16.Cantor Fitzgerald initiated its Overweight rating on January 20, 2021, with a $16 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 18 ’24 when Oliviero James F III sold 602,167 shares for $3.87 per share. The transaction valued at 2,330,386 led to the insider holds 3,414,813 shares of the business.

Oliviero James F III sold 220,230 shares of CKPT for $744,377 on Dec 19 ’24. The CEO, President and Director now owns 3,194,583 shares after completing the transaction at $3.38 per share. On Dec 18 ’24, another insider, GRAY WILLIAM GARRETT, who serves as the Chief Financial Officer of the company, sold 268,432 shares for $4.01 each. As a result, the insider received 1,076,412 and left with 1,032,754 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CKPT now has a Market Capitalization of 177750304 and an Enterprise Value of 150360544. For the stock, the TTM Price-to-Sale (P/S) ratio is 3655.42. Its current Enterprise Value per Revenue stands at 1927.699.

Stock Price History:

Over the past 52 weeks, CKPT has reached a high of $4.50, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is 1.12%, while the 200-Day Moving Average is calculated to be 49.04%.

Shares Statistics:

According to the various share statistics, CKPT traded on average about 1.33M shares per day over the past 3-months and 3726030 shares per day over the past 10 days. A total of 45.10M shares are outstanding, with a floating share count of 38.39M. Insiders hold about 21.38% of the company’s shares, while institutions hold 15.76% stake in the company. Shares short for CKPT as of 1730332800 were 5563543 with a Short Ratio of 5.12, compared to 1727654400 on 4375843. Therefore, it implies a Short% of Shares Outstanding of 5563543 and a Short% of Float of 13.370000000000001.

Most Popular